Herrmann A. John's Insider Trades & SAST Disclosures
Herrmann A. John's most recent trade in Novavax, Inc. was a trade of 2,100 Common Stock done . Disclosure was reported to the exchange on Dec. 14, 2023.
Add Superstar Alert
Note
This is a custom search result for pattern Herrmann A. John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 2,100 | 13,933 (0%) | 0% | - | Common Stock | |
|
Novavax, Inc.
|
Herrmann A. John | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 2,100 | 0 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
A. John Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.69 per share. | 14 Dec 2023 | 700 | 13,233 (0%) | 0% | 5.7 | 3,983 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2023 | 833 | 0 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2023 | 833 | 12,111 (0%) | 0% | - | Common Stock | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.70 per share. | 25 Jun 2023 | 278 | 11,833 (0%) | 0% | 6.7 | 1,863 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 4,609 | 9,216 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.52 per share. | 10 Mar 2023 | 4,609 | 13,058 (0%) | 0% | 6.5 | 30,051 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.52 per share. | 10 Mar 2023 | 1,780 | 11,278 (0%) | 0% | 6.5 | 11,606 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 44,280 | 44,280 | - | - | Stock Option (Right to Buy) | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 38,330 | 38,330 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,973 | 8,373 (0%) | 0% | - | Common Stock | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 3,973 | 0 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 26 Sep 2022 | 1,324 | 7,049 (0%) | 0% | 18.9 | 24,984 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 667 | 0 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Sep 2022 | 667 | 3,642 (0%) | 0% | - | Common Stock | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. | 26 Sep 2022 | 258 | 3,384 (0%) | 0% | 18.9 | 4,868 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 2,000 | 0 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2022 | 2,000 | 3,747 (0%) | 0% | - | Common Stock | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.07 per share. | 24 Aug 2022 | 772 | 2,975 (0%) | 0% | 37.1 | 28,618 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 833 | 833 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2022 | 833 | 4,678 (0%) | 0% | - | Common Stock | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.67 per share. | 25 Jun 2022 | 278 | 4,400 (0%) | 0% | 51.7 | 14,364 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 20,737 | 20,737 | - | - | Stock Option (Right to Buy) | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 13,825 | 13,825 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 03 Jan 2022 | 5,000 | 8,845 (0%) | 0% | 19.1 | 95,400 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 5,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 143.64 per share. | 03 Jan 2022 | 1,003 | 3,945 (0%) | 0% | 143.6 | 144,070 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 139.08 per share. | 03 Jan 2022 | 997 | 7,048 (0%) | 0% | 139.1 | 138,660 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 142.65 per share. | 03 Jan 2022 | 800 | 4,948 (0%) | 0% | 142.6 | 114,117 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 141.69 per share. | 03 Jan 2022 | 800 | 5,748 (0%) | 0% | 141.7 | 113,350 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 140.05 per share. | 03 Jan 2022 | 500 | 6,548 (0%) | 0% | 140.1 | 70,026 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 136.82 per share. | 03 Jan 2022 | 400 | 8,445 (0%) | 0% | 136.8 | 54,728 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 137.85 per share. | 03 Jan 2022 | 400 | 8,045 (0%) | 0% | 137.9 | 55,140 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 144.43 per share. | 03 Jan 2022 | 100 | 3,845 (0%) | 0% | 144.4 | 14,443 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Dec 2021 | 5,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 20 Dec 2021 | 5,000 | 8,845 (0%) | 0% | 19.1 | 95,400 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 230.00 per share. | 20 Dec 2021 | 5,000 | 3,845 (0%) | 0% | 230 | 1,150,000 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,100 | 4,200 | - | - | Restricted Stock Units | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,100 | 4,860 (0%) | 0% | - | Common Stock | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.43 per share. | 14 Dec 2021 | 1,015 | 3,845 (0%) | 0% | 168.4 | 170,956 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 228.72 per share. | 29 Nov 2021 | 5,000 | 2,760 (0%) | 0% | 228.7 | 1,143,600 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Nov 2021 | 5,000 | 95,000 | - | - | Stock Option (Right to Buy) | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 29 Nov 2021 | 5,000 | 7,760 (0%) | 0% | 19.1 | 95,400 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 03 Nov 2021 | 5,000 | 2,760 (0%) | 0% | 200 | 1,000,000 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 03 Nov 2021 | 5,000 | 7,760 (0%) | 0% | 19.1 | 95,400 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2021 | 5,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 01 Nov 2021 | 5,000 | 7,760 (0%) | 0% | 19.1 | 95,400 | Common Stock |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 5,000 | 105,000 | - | - | Stock Option (Right to Buy) | |
|
Novavax, Inc.
|
John A. Herrmann | EVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 157.42 per share. | 01 Nov 2021 | 800 | 6,260 (0%) | 0% | 157.4 | 125,936 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges